Priority voucher awardees and regulators could feel pressure to “meet the moment” as FDA watchers question the intent and ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

Trump deals with Eli Lilly and Novo Nordisk increase access to obesity drugs, providing a safe, convenient way to slim down ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

Eli Lilly is well on its way to the trillion-dollar club. The stock price is up 30% so far this year; with a total ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...

Viking Therapeutics shares have delivered explosive gains this week, climbing to their highest level in ten months. The ...

Pfizer eventually increased its offer. The company is now set to acquire Metsera in a deal worth up to $10 billion, including ...

European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling ...

On Friday, Cees de Jong was named vice chair, replacing Henrik Poulsen. Britt Meelby Jensen and Stephan Engels were appointed as new board members. The company plans to seek the election of Helena ...